These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31710751)

  • 1. Reply to letter: Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis.
    Alves M; Caldeira D; Ferro JM; Ferreira JJ
    Eur J Neurol; 2020 Feb; 27(2):e12. PubMed ID: 31710751
    [No Abstract]   [Full Text] [Related]  

  • 2. Readers response to: Does Parkinson's disease increase the risk of cardiovascular events?
    Castillo-Torres SA; Estrada-Bellmann I; Martínez-Roque DG; Olguín-Ramírez LA; Meléndez-Flores JD; Chávez-Luévanos B; Góngora-Rivera F
    Eur J Neurol; 2020 Feb; 27(2):e11. PubMed ID: 31670449
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: Risk of myocardial infarction in Parkinson's disease: A systematic review and meta-analysis.
    Liu J; Wang T; Li X
    Eur J Neurol; 2023 Oct; 30(10):3407-3408. PubMed ID: 37335519
    [No Abstract]   [Full Text] [Related]  

  • 4. Stroke and its modification in Parkinson's disease.
    Struck LK; Rodnitzky RL; Dobson JK
    Stroke; 1990 Oct; 21(10):1395-9. PubMed ID: 2219202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between physical fitness, cardiovascular risk factors, and Parkinson's disease.
    Müller J; Myers J
    Eur J Prev Cardiol; 2018 Sep; 25(13):1409-1415. PubMed ID: 29667433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses.
    Bellou V; Belbasis L; Tzoulaki I; Evangelou E; Ioannidis JP
    Parkinsonism Relat Disord; 2016 Feb; 23():1-9. PubMed ID: 26739246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke and Parkinson's disease.
    Levine RL; Jones JC; Bee N
    Stroke; 1992 Jun; 23(6):839-42. PubMed ID: 1595102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to letter: Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials.
    Rodrigues TM; Castro Caldas A; Ferreira JJ
    Parkinsonism Relat Disord; 2016 Aug; 29():123-4. PubMed ID: 27237107
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of Tai Chi and Qigong on health-related quality of life in Parkinson's disease: a systematic review and meta-analysis of systematic reviews.
    Fidan O; Seyyar GK; Aras B; Colak E; Aras O
    Int J Rehabil Res; 2019 Sep; 42(3):196-204. PubMed ID: 31116118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraquat exposure and Parkinson's disease: A systematic review and meta-analysis.
    Tangamornsuksan W; Lohitnavy O; Sruamsiri R; Chaiyakunapruk N; Norman Scholfield C; Reisfeld B; Lohitnavy M
    Arch Environ Occup Health; 2019; 74(5):225-238. PubMed ID: 30474499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome in Parkinson's disease and increased cardiovascular risk.
    Silva MME; Lorenzi CH; Schneider BB; Seidel CEF; Salomé I; Gianini VCM; Pessoa RR; Mercer PBS; Witt MCZ
    Arq Neuropsiquiatr; 2018 Nov; 76(11):731-735. PubMed ID: 30570015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to the letter 'We never speak about sudden unexpected death in Parkinson's disease'.
    Alves M; Caldeira D; Ferro JM; Ferreira JJ
    Eur J Neurol; 2020 Jul; 27(7):e29. PubMed ID: 32176407
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin usage, vascular diagnosis and vascular risk factors in Parkinson's disease.
    Cheng KK; Swallow DM; Grosset KA; Grosset DG
    Scott Med J; 2017 Aug; 62(3):104-109. PubMed ID: 28836927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses.
    Gunnarsson LG; Bodin L
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30691095
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone.
    Graham DJ; Williams JR; Hsueh YH; Calia K; Levenson M; Pinheiro SP; Macurdy TE; Shih D; Worrall C; Kelman JA
    Mov Disord; 2013 Apr; 28(4):490-7. PubMed ID: 23443994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii infection and risk of Parkinson and Alzheimer diseases: A systematic review and meta-analysis on observational studies.
    Bayani M; Riahi SM; Bazrafshan N; Ray Gamble H; Rostami A
    Acta Trop; 2019 Aug; 196():165-171. PubMed ID: 31102579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and Parkinson's disease.
    Godwin-Austen RB; Lee PN; Marmot MG; Stern GM
    J Neurol Neurosurg Psychiatry; 1982 Jul; 45(7):577-81. PubMed ID: 7119826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely Low Frequency Magnetic Field Exposure and Parkinson's Disease--A Systematic Review and Meta-Analysis of the Data.
    Huss A; Koeman T; Kromhout H; Vermeulen R
    Int J Environ Res Public Health; 2015 Jun; 12(7):7348-56. PubMed ID: 26133127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of advanced age and/or systemic medical conditions on dental implant survival: A systematic review and meta-analysis.
    Schimmel M; Srinivasan M; McKenna G; Müller F
    Clin Oral Implants Res; 2018 Oct; 29 Suppl 16():311-330. PubMed ID: 30328186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen.
    De Vecchis R; Baldi C; Di Biase G; Ariano C; Cioppa C; Giasi A; Valente L; Cantatrione S
    Minerva Cardioangiol; 2014 Dec; 62(6):437-48. PubMed ID: 25029569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.